Hippocampal neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study

Psychiatry Research - Neuroimaging

Volumn 201, Issue 3, 2012, Pages 206-213

  Husarova, Veronika ^a   Bittsansky, Michal ^b   Ondrejka, Igor ^a   Kerna, Valeria ^a   Dobrota, Dusan ^b  

^a Martinska Fakultna Nemocnica   (Slovakia)

^b University Teaching Hospital in Martin   (Slovakia)

Author keywords

Hippocampus; Lactate; Myo inositol

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; VENLAFAXINE;

ADULT; ANAEROBIC GLYCOLYSIS; ARTICLE; ASTROCYTE; CELL COUNT; CELL FUNCTION; CLINICAL ARTICLE; DEPRESSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HIPPOCAMPUS; HUMAN; INTRACELLULAR SIGNALING; MALE; METABOLISM; MONOTHERAPY; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; CHOLINE; CREATINE; DEPRESSION; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TRITIUM; YOUNG ADULT;

EID: 84861455366     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.07.006     Document Type: Article

References (71)

1. Atlas S.W. Magnetic Resonance Imaging of the Brain and Spine 2009, 1845. Lippincott Williams & Wilkins, Philadelphia. 4th ed.
2. Austin M.P., Dougall N., Ross M., Murray C., O'Carroll R.E., Moffoot A., Ebmeier K.P., Goodwin G.M. Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. Journal of Affective Disorders 1992, 26:31-43.
3. Barker P.B., Breiter S.N., Soher B.J., Chatham J.C., Forder J.R., Samphilipo M.A., Magee C.A., Anderson J.H. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magnetic Resonance in Medicine 1994, 32:157-163.
4. Barkho B.Z., Song H., Aimone J.B., Smrt R.D., Kuwabara T., Nakashima K., Gage F.H., Zhao X. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells and Development 2006, 15:407-421.
5. Becker S., Wojtowicz J.M. A model of hippocampal neurogenesis in memory and mood disorders. Trends in Cognitive Sciences 2007, 11:70-76.
6. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Boorman E., Matthews M.P., Cowen J.P. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. The International Journal of Neuropsychopharmacology 2007, 11:255-260.
7. Block W., Träber F., von Widdern O., Metten M., Schild H., Maier W., Zobel A., Jessen F. Proton MR spectroscopy of the hippocampus at 3T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. The International Journal of Neuropsychopharmacology 2009, 12:415-422.
8. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., Phelps M.E., Huang S.C., Wu H.M., Ho M.L., Ho M.K., Au S.C., Maidment K., Baxter L.R. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Archives of General Psychiatry 2001, 58:631-640.
9. Castrén E., Võikar V., Rantamäki T. Role of neurotrophic factors in depression. Current Opinion in Pharmacology 2007, 7:18-21.
10. Cihak R. Anatomie 3 1997, 391-397. Grada Publishing spol.s.r.o, Praha. 1st ed.
11. Coffey C.E., Wilkinson W.E., Weiner R.D., Parashos I.A., Djang W.T., Webb M.C., Figiel G.S., Spritzer C.E. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Archives of General Psychiatry 1993, 50:7-16.
12. Dan V., Iosifescu M.D., Renshaw P.F. 31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression. Harvard Review of Psychiatry 2003, 11:51-63.
13. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54:597-606.
14. Ende G., Braus D.F., Walter S., Weber-Fahr W., Henn F.A. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Archives of General Psychiatry 2000, 57:937-943.
15. Fisar Z. Vybrané kapitoly z biologické psychiatrie 2009, 384. Grada Publishing, a.s., Praha. 2nd ed.
16. Frey R., Metzler D., Fischer P., Heiden A. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 15 Tesla. Journal of Psychiatric Research 1998, 32:411-420.
17. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nature Reviews. Neuroscience 2003, 4:1002-1012.
18. Gilbertson M.W., Shenton M.E., Ciszewski A., Kasai K., Lasko N.B., Orr S.P., Pitman R.K. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neuroscience 2002, 5:1242-1247.
19. Gonul A.S., Kitis O., Ozan E., Akdeniz F., Eker C., Eker O.D., Vahip S. The effect on antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30:120-125.
20. Hamakawa H., Kato T., Murashita J., Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives of Psychiatry and Clinical Neuroscience 1998, 248:53-58.
21. Hamakawa H., Murashita J., Yamada N., Inubushi T., Kato N., Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry and Clinical Neurosciences 2003, 58:82-88.
22. Henn F.A., Vollmayr B. Neurogenesis and depression: etiology or epiphenomenon?. Biological Psychiatry 2004, 56:146-150.
23. Hertz L. The astrocyte-neuron lactate shuttle: a challenge of a challenge. Journal of Cerebral Blood Flow and Metabolism 2004, 24:1241-1248.
24. Hong S.T., Choi C.B., Park C., Moon H.Y., Hong K.S., Cheong C., Chae J.H., Choe B.Y. Specific hippocampal choline decrease in an animal model of depression. The British Journal of Radiology 2009, 82:549-553.
25. Huang Y., Chen W., Li Y., Wu X., Shi X., Geng D. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy. Psychiatry Research 2010, 182:48-52.
26. Isaacks R.E., Bender A.S., Kim C.Y., Prieto N.M., Norenberg M.D. Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochemical Research 1994, 19:331-338.
27. Itoh T., Satou T., Nishida S., Hashimoto S., Ito H. Cultured rat astrocytes give rise to neural stem cells. Neurochemical Research 2006, 31:1381-1387.
28. Jacobs B.L. Adult brain neurogenesis and depression. Brain, Behavior, and Immunity 2002, 16:602-609.
29. Kato T., Kato M. Mitochondrial dysfunction in bipolar disorder. Bipolar Disorders 2000, 2:180-190.
30. Kaymak S.U., Demir B., Oǧuz K.K., Sentürk S., Uluǧ B. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression. Psychiatry and Clinical Neurosciences 2009, 63:350-356.
31. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. The American Journal of Psychiatry 2001, 158:899-905.
32. Kozisek N.E., Middlemas D., Bylund D.B. Brain-derived neurotrophic factor and its receptor tropomyosin-related konase B in the mechanism of action of antidepressant therapies. Pharmacology & Therapeutics 2008, 117:30-51.
33. Kronmüller K.T., Pantel J., Köhler S., Victor D., Giesel F., Magnotta V.A., Mundt C., Essig M., Schröder J. Hippocampal volume and 2-year outcome in depression. The British Journal of Psychiatry 2008, 192:472-473.
34. Kusumakar V., MacMaster F.P., Gates L., Sparkes S.J., Khan S.C. Left medial temporal cytosolic choline in early onset depression. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2001, 46:959-964.
35. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1995, 19:11-38.
36. Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on demand. Science 1999, 283:496-497.
37. Manev H., Uz T., Manev R. Glia as a putative target for antidepressant treatments. Journal of Affective Disorders 2003, 75:59-64.
38. Mangia S., Simpson I.A., Vannucci S.J., Carruthers A.J. The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. Neurochemical Journal 2009, 109(Suppl. 1):55-62.
39. Manji H.K., Bersudsky Y., Chen G., Belmaker R.H., Potter W.Z. Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacology 1996, 15:370-381.
40. Mason G.F., Krystal J.H. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. NMR in Biomedicine 2006, 19:690-701.
41. Mattson M.P., Gleichmann M., Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
42. Mayberg H.S., Lewis P.J., Regenold W., Wagner H.N. Paralimbic hypoperfusion in unipolar depression. Journal of Nuclear Medicine 1994, 35:929-934.
43. Mervaala E., Föhr J., Könönen M., Valkonen-Korhonen M., Vainio P., Partanen K., Partanen J., Tiihonen J., Viinamäki H., Karjalainen A.K., Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychological Medicine 2000, 30:117-125.
44. Michael N., Erfurth A., Ohrmann P., Arolt V., Heindel W., Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychological Medicine 2003, 33:1277-1284.
45. Michael N., Erfurth A., Ohrmann P., Arolt V., Heindel W., Pfleiderer B. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology 2003, 28:720-725.
46. Mirza Y., O'Neill J., Smith E.A., Russell A., Smith J.M., Banerjee S.P., Bhandari R., Boyd C., Rose M., Ivey J., Renshaw P.F., Rosenberg D.R. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. Journal of Child Neurology 2006, 21:106-111.
47. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry 1979, 134:382-389.
48. Mu J., Xie P., Yang Z.S., Yang D.L., Lv F.J., Luo T.Y., Li Y. 1H magnetic resonance spectroscopy study of thalamus in treatment resistant depressive patients. Neuroscience Letters 2007, 425:49-52.
49. Navarro V., Gasto C., Lomena F., Mateos J.J., Marcos T., Portella M.J. Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study. NeuroImage 2002, 16:781-787.
50. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Research 1996, 723:37-45.
51. Patel N.C., Cecil K.M., Strakowski S.M., Adler C.M., DelBello M.P. Neurochemical alterations in adolescent bipolar depressiona a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex. Journal of Child and Adolescent Psychopharmacology 2008, 18:623-627.
52. Pav M., Kovaru H., Fiserova A., Havrdova E., Lisa V. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. Physiological Research 2008, 57:151-164.
53. Pouwels P.J., Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magnetic Resonance in Medicine 1998, 39:53-60.
54. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 1993, 30:672.
55. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry 2000, 48:766-777.
56. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 1999, 45:1085-1098.
57. Rakic P. Neurogenesis in adult primate neocortex: an evaluation of the evidence. Nature Reviews. Neuroscience 2002, 3:65-71.
58. Renshaw P.F., Lafer B., Babb S.M., Fava M., Stoll A.L., Christensen J.D., Moore C.M., Yurgelun-Todd D.A., Bonello C.M., Pillay S.S., Rothschild A.J., Nierenberg A.A., Rosenbaum J.F., Cohen B.M. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 1997, 41:837-843.
59. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
60. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:3908-3913.
61. Sibson N.R., Dhankhar A., Mason G.F., Rothman D.L., Behar K.L., Shulman R.G. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proceedings of the National Academy of Sciences of The United States of America. Physical Sciences 1998, 95:316-321.
62. Sierralta W., Hernández A., Valladares L., Pérez H., Mondaca M., Soto-Moyano R. Mild prenatal protein malnutrition increases alpha 2C-adrenoceptor expression in the rat cerebral cortex during postnatal life. Brain Research Bulletin 2006, 69:580-586.
63. Sonawalla S.B., Renshaw P.F., Moore C.M., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., Fava M. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. The American Journal of Psychiatry 1999, 156:1638-1640.
64. Steingard R.J., Yurgelun-Todd D.A., Hennen J., Moore J.C., Moore C.M., Vakili K., Young A.D., Katic A., Beardslee W.R., Renshaw P.F. Increased orbitofrontal cortex levels of cytosolic choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biological Psychiatry 2000, 48:1053-1061.
65. Stork C., Renshaw P.F. Mitochondrial dysfunction inbipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 2005, 10:900-919.
66. Turner C.A., Akil H., Watson S.J., Evans S.J. The fibroblast growth factor system and mood disorders. Biological Psychiatry 2006, 59:1128-1135.
67. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., Murray C.J. Global burden of depressive disorders in the year 2000. The British Journal of Psychiatry 2004, 184:386-392.
68. Vaidya V.A., Duman R.S. Depression-emerging insights from neurobiology. British Medical Bulletin 2001, 57:61-79.
69. Venkatraman T.N., Krishnan R.R., Steffens D.C., Song A.W., Taylor W.D. Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression. Psychiatry Research: Research 2009, 172:49-54.
70. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. The American Journal of Psychiatry 2004, 161:1957-1966.
71. Yang R., Wu X.P., Bai X.Y., Ning W.D., Yang J.L., Xie Z.C. Proton magnetic resonance spectroscopy of the thalamus and hypothalamus in patients with first-episode depression. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29:2442-2445.